Chengdu IXING Biotechnology Co.
Latest round
- Series B
Last raised
- May 2020
Total raised
- $2.8M
Investors
- 3
About Chengdu IXING Biotechnology Co.
, Ltd. is an IVD company focusing on precise POCT technology platforms and products, with two R&D centers in Chengdu and Shanghai. In April 2021, seven products has obtained CE certificates. In January 2019, IXING obtained the production license. The company's products can be categorized into Point-of-care Testing (POCT) equipment and reagents, which can be applied in laboratories, outpatient clinics, emergency clinics, medical examination centers, health centers, etc. The reagents include cardiovascular and cerebrovascular disease rapid diagnosis series, infection and inflammation series, kidney injury series, maternal health series, and gastric function series. It also provides myocardial complex quality control products and inflammation complex quality control products.
Who invested in Chengdu IXING Biotechnology Co.
3 investors across 3 rounds
See all investors in Chengdu IXING Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chengdu IXING Biotechnology Co.
Who invested in Chengdu IXING Biotechnology Co.?
Chengdu IXING Biotechnology Co. has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chengdu IXING Biotechnology Co. raised?
Chengdu IXING Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Chengdu IXING Biotechnology Co. last raise money?
Chengdu IXING Biotechnology Co.'s most recent round on record is a Series B, in May 2020.
What does Chengdu IXING Biotechnology Co. do?
Chengdu IXING Biotechnology Co. is a medical devices & equipment company.
Where is Chengdu IXING Biotechnology Co. headquartered?
Chengdu IXING Biotechnology Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Chengdu IXING Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Chengdu IXING Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Chengdu IXING Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.